Health-related quality of life after vertebral or hip fracture: a seven-year follow-up study by Hallberg, Inger et al.
BioMed  Central
Page 1 of 13
(page number not for citation purposes)
BMC Musculoskeletal Disorders
Open Access Research article
Health-related quality of life after vertebral or hip fracture: a 
seven-year follow-up study
Inger Hallberg*1,4, Margareta Bachrach-Lindström1, Staffan Hammerby2, 
Göran Toss3,4 and Anna-Christina Ek1
Address: 1Department of Medical and Health Sciences, Division of Nursing Science, Faculty of Health Sciences, Linköping University, SE-581 85 
Linköping, Sweden, 2Department of Medical and Health Sciences, Division of Radiological Science, Faculty of Health Sciences, Linköping 
University, SE-581 85 Linköping, Sweden, 3Department of Medical and Health Sciences, Division of Cardiovascular Medicine/Internal Medicine, 
Faculty of Health Sciences, Linköping University, SE-581 85 Linköping, Sweden and 4Department of Endocrinology & Gastroenterology University 
Hospital/Osteoporosis Unit, SE-581 85 Linköping, Sweden
Email: Inger Hallberg* - inger.hallberg@liu.se; Margareta Bachrach-Lindström - margareta.bachrach-lindstrom@liu.se; 
Staffan Hammerby - staffan.hammerby@lio.se; Göran Toss - goran.toss@lio.se; Anna-Christina Ek - anna-christina.ek@liu.se
* Corresponding author    
Abstract
Background: The negative impact of vertebral and hip low-energy fractures on health-related quality-of-life (HRQOL)
has been demonstrated previously, but few prospective long-term follow-up studies have been conducted. This study
aims to (i) investigate the changes and long-term impact of vertebral or hip fracture and between fracture groups on
HRQOL in postmenopausal women prospectively between two and seven years after the inclusion fracture, (ii) compare
HRQOL results between fracture and reference groups and (iii) study the relationship between HRQOL and physical
performance, spinal deformity index and bone mineral density at seven-year follow-up.
Methods: Ninety-one women examined two years after a low-energy vertebral or hip fracture were invited to a new
examination seven years after the diagnosis. HRQOL was examined using the SF-36 questionnaire and was compared
with an age and sex-matched reference group. Physical function was assessed using tests and questionnaires. Bone
mineral density was measured. Radiographs of the spine were evaluated using the visual semiquantitative technique. A
longitudinal and cross-sectional design was used in this study. Statistical analyses included descriptive statistics, Student's
t-tests, ANCOVA, and partial correlation.
Results: Sixty-seven women participated. In the 42 women (mean age 75.8, SD 4.7) with vertebral fracture as inclusion
fracture, bodily pain had deteriorated between two and seven years and might be explained by new fracture. Remaining
pronounced reduction of HRQOL was seen in all domains except general health and mental health at seven-year follow-
up in women with vertebral fractures compared to the reference group (p < 0.05). All 25 women (mean age 75.0, SD
4.7) with hip fracture as inclusion fracture had no significant changes in HRQOL between two and seven years and did
not differ from the reference group regarding HRQOL after seven years. The vertebral group had significantly lower
values for bodily pain, vitality, role-emotional function and mental health compared to the hip group. HRQOL showed a
positive relationship between physical activity, static balance and handgrip strength.
Conclusion: The long-term reduction of HRQOL in women with vertebral fracture emerged clearly in this study. The
relationships between HRQOL and physical performance in women with vertebral and hip fracture raise questions for
more research.
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Background
The global burden of osteoporosis includes considerable
numbers of fractures, morbidity, mortality and expenses,
due mainly to vertebral, hip and forearm fractures [1-4].
Osteoporosis causes no symptoms except for fractures and
their complications. All fractures may lead to disability or
impairment of health-related quality of life (HRQOL),
particularly those of the hip and vertebrae [5-7]. Vertebral
fractures are the most common of all osteoporotic frac-
tures, and underdiagnosis of vertebral fracture is a world-
wide problem [8]. Furthermore, vertebral and hip
fractures are linked to increased mortality [9-12].
Several studies have shown more or less severe impair-
ment of HRQOL in patients who have experienced verte-
bral or hip fractures [5]. The extent to which the
impairment of HRQOL is due to fractures or other co-
morbidity or biological ageing is not known. In elderly
people with osteoporosis, impairment of balance has
been reported [13]. A recent study has also reported that
balance impairment is related more to vertebral fracture
than to thoracic kyphosis in women with osteoporosis
[14]. Handgrip strength is necessary for performing activ-
ities of daily living and is essential for maintaining func-
tional autonomy, and may also mirror ageing and frailty.
Fractures and pain are independently related to lower
handgrip strength and walking speed [15]. Further studies
are needed on the role of these factors in HRQOL after
fractures.
Vertebral fracture can be classified into two major catego-
ries, subclinical and clinical. Studies of patients with sub-
clinical as well as clinical vertebral fractures show
association with decrements in function and HRQOL. The
decrement is greater when the number of fractures is
higher and the severity is greater [16,17].
It is noteworthy that only a few clinical trials have shown
treatment benefits regarding HRQOL [18-21]. Several
recent cross-sectional studies [22-25] and some follow-up
studies [26-30] of HRQOL after fracture have been pub-
lished, but the long-term impact of osteoporotic fractures
on HRQOL has not been prospectively or sufficiently
examined. In a previous study [29] we reported that verte-
bral and hip fractures have a considerably greater and
more prolonged impact on HRQOL than do forearm and
humerus fractures. HRQOL was significantly reduced at
baseline regarding all SF-36 domains after vertebral and
mostly hip fracture, but only regarding some domains
after forearm and humerus fracture. However, two years
after hip fracture, HRQOL had improved but was below
normal in the domains of physical functioning, physical
role and social function, while after vertebral fracture,
although physical function, role-physical, bodily pain and
social function had improved, all domains were still sig-
nificantly below reference values [29]. Since there is a lack
of data regarding HRQOL from long-term follow-up stud-
ies after vertebral or hip fracture, this study was designed
to measure HRQOL approximately seven years after verte-
bral or hip fracture.
The objectives of the present study were to (i) investigate
the changes and long-term impact of vertebral or hip frac-
ture and between fracture groups on HRQOL in postmen-
opausal women prospectively between two and seven
years after the inclusion fracture, (ii) compare HRQOL
results between fracture and reference groups and (iii)
study the relationship between HRQOL and physical per-
formance, spinal deformity index and bone mineral den-
sity at seven-year follow-up.
Methods
Patient Group
The main inclusion criterion was participation in and
completion of the previous two-year follow-up study of
women with a newly diagnosed vertebral or hip low-
energy fracture, in this paper called the inclusion fracture.
The exclusion criteria were refusal to participate and
impairment of mental or physical health hindering a sub-
ject from providing measurement, correct information
and completing the questionnaire.
The participants were invited by phone and post during
the period of February through August 2006. The seven-
year follow-up was performed a mean of 7.0 years (SD
0.5) after baseline examination. The examinations took
place at the University Hospital in Linköping and the oste-
oporosis unit at Ryhov Hospital in Jönköping, in Sweden.
Patients were originally recruited through a written invita-
tion sent to 600 consecutive women with a new low-
energy fracture of the distal forearm, proximal humerus,
vertebra or hip, as described earlier [29,31]. In the base-
line study, 40 women were included after a hip fracture
and 55 after a vertebral fracture. The total dropout from
baseline to seven-year follow-up was 29% (n = 28). Of
these 95 women, seven refused the follow-up visit and
three refused the radiological examinations of the spine.
Four were excluded due to stroke or dementia, and 14
(three from the hip fracture group and 11 from the verte-
bral fracture group) had died. Mortality since the two-year
follow-up was three in the hip group and ten in the verte-
bral fracture group. The remaining 67 women were
included in the study. A flowchart from baseline to two-
year and seven-year follow-up is shown in Figure 1.
A dropout analysis between the missing group (n = 24)
and the women (n = 67) participating in the seven-year
follow-up, using certain data from the two-year follow-up,
showed that the missing group had significantly lower
values regarding the SF-36 within the general health andBMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
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social function domains. They had also lower weight,
body mass index and bone mineral density in the hip. Age
did not differ.
At two-year follow-up, the patients were prescribed con-
tinued osteoporosis medication (usually bisphosphonate,
vitamin D and calcium) for the ensuing year, and were
referred to their general practitioner for further treatment.
Reference Group
An age and sex-matched reference group was chosen from
a large local population study in Östergötland County,
Sweden, called "Östgötens Hälsa 2006", to obtain norma-
tive values for HRQOL measured using the Short Form 36
(SF-36) questionnaire. The reference group was handled
like a normal background population, recruited from the
same general population area during 2006. The SF-36 was
mailed to a stratified random sample of 13,440 people
aged 18 to 84 years. After two reminders, 7,238 (54%)
had responded. For the women aged 65 to 84, 1,144
(68%) had responded. The population study comprised
804 women aged 64 to 82 years, who formed the reference
group (mean age 75.7, SD 4.7). From the reference group,
women aged 70 and 75 years were compared and showed
stable values in all domains, except for vitality, which was
significantly lower in the elderly women (59.0 vs. 69.7)
[32].
Design
In this study, a longitudinal design was used to answer the
purpose (i) and a cross-sectional for (ii) and (iii). The par-
ticipants gave their oral informed consent before the visit
and written informed consent at the visit. The study was
approved by the Regional Ethical Review Board at the Fac-
ulty of Health Sciences, University of Linköping 2005, reg-
istration no. M173-05, and was performed in accordance
with the Declaration of Helsinki.
Flowchart of participant recruitment, inclusion and dropout Figure 1
Flowchart of participant recruitment, inclusion and dropout.
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Outcomes
The Short Form 36 (SF-36, version 1) of the Medical Out-
come Study was used as a main outcome measure of
HRQOL [33]. Studied as putative predictors were some
specific background data from a self-administered ques-
tionnaire, body mass index, physical function evaluated
with handgrip strength and one-leg static balance testing,
bone mineral density and vertebral fracture assessment.
Background Data
Before a patient's visit to the osteoporosis unit, a self-
administered questionnaire was sent to her containing
questions about previous fractures, falls, concomitant dis-
eases, treatments and lifestyle factors (physical activity,
calcium intake and smoking) of importance for oste-
oporosis and fracture risk. A seven-grade scale was used to
assess leisure-time physical activity level, modified from
the original four-grade scale by Saltin and Grimby [34].
The physical activity levels included household and lei-
sure-time activities. The lowest grade of physical activity
was 1, while 7 was denoted as the "high level". A verbal
graphic rating scale (GRS) was used to measure present
and recalled back pain, for the previous two weeks. The
scale used descriptors along a continuum (none-insignifi-
cant-mild-moderate-severe-unbearable). Absence of pain
was rated as 0 mm, and the worst possible pain as 100
mm [35].
Short Form 36 (SF-36)
The SF-36 questionnaire was sent to the patient before the
visit, and she was asked to answer the questions on her
own. If she had not completed the questionnaire before
arriving at the unit, she was encouraged to do so before
the examination started.
The SF-36 questionnaire comprises 36 items, with two to
six response options according to an ordinal scale, assess-
ing eight health concepts or domains: physical function
(PF), role limitations due to physical health problems
(RP), bodily pain (BP), general health (GH), vitality (VT),
social function (SF), role limitations due to emotional
problems (RE) and mental health (MH). Each domain
allowed a score of 0-100, with a high score indicating bet-
ter HRQOL. The SF-36 has been evaluated extensively
regarding both reliability and validity according to Swed-
ish conditions [36-38].
Clinical Tests
During the visit, each patient was assessed by the first
author (IH). Body height (m) was registered using a stadi-
ometer and body weight (kg) using a calibrated scale.
Body mass index (BMI) was calculated using the formula
kg/m2. Body height and weight were measured in indoor
clothes without shoes. Physical function was assessed by
measuring handgrip strength and one-leg static balance
testing. Handgrip strength (kg) was measured in the dom-
inant hand using the standard JAMAR, an electronic
dynamometer. For standardization, the adjustable handle
was set at the second position for all women. Participants
sat comfortably with their elbow flexed at 90 degrees and
their shoulder adducted and neutrally rotated. Each test
was performed three times and the mean value was used.
Reference values were obtained from Mathiowetz et al.
[39] and were adapted to the metric system. The calibra-
tion of the instrument was tested periodically during the
study. Mathiowetz has recommended the use of the mean
of three tests, to achieve the highest test-retest reliability.
Static balance was assessed by asking the patients to stand
on only their dominant leg with their eyes open. The one-
leg-stance tests were performed without shoes with the
opposite foot lifted halfway up on the calf of the sup-
ported leg and the arms in vertical position. The time was
recorded until the supporting foot was moved from its ini-
tial position. The static balance tests were timed with a
digital stopwatch and were limited to a maximum of 30 s.
Static balance tests were performed three times, and the
best value on one's dominant leg was used in the final
score [40,41].
Bone Mineral Density
Bone mineral density (BMD) was measured using dual-
energy X-ray absorptiometry (DXA, Hologic QDR 4500 A;
Hologic Inc., Bedford, MA) of the lumbar spine and hip,
non-dominant side. Internal variation was checked regu-
larly with an everyday calibration using a phantom. As a
reference for BMD in the hip we used the NHANES III [42]
and for BMD in the spine, reference data published by
Favus [43].
A patient was classified as osteoporotic if T-score was 2.5
or more standard deviations (SD) below the mean value
of young normal (T-score ≤-2.5) at lumbar spine or hip
total, and osteopenic if the lowest of these values was
between <-1 and >-2.5 SD [44]. In comparing BMD with
the age-matched general population, Z-score was used.
Specially trained nurses (DXA operators) performed the
measurements.
Vertebral Fracture Assessment
A lateral digital radiograph of the thoracic and lumbar
spine was performed within four months after the visit
date, except in one woman who was examined nine
months before the visit date. Three women with vertebral
fracture as inclusion fracture at the baseline examination
refused radiological examination at seven-year follow-up;
thus the true incidence of new vertebral fracture is
unknown. The number and grade of vertebral deformities
were assessed according to the Genant visual semiquanti-
tative criteria [45,46]. Each of the T4 to L4 vertebrae was
thus assigned a grade of 0, 1, 2 or 3. Zero indicates no frac-BMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
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ture (deformity), 1 a mild (20-25%), 2 a moderate (25-
40%) and grade 3 a severe (>40%) height reduction in the
anterior, central and/or posterior part, respectively. A Spi-
nal Deformity Index (SDI, range 0-39) was calculated by
adding the deformity grades. All the radiological examina-
tions were evaluated by the same experienced skeletal
radiologist (SH).
Statistical Analyses
Group results are reported as mean value (M), standard
deviation (SD), confidence interval (CI) and percent. Dif-
ferences in basic characteristics between vertebral and hip
fracture groups were tested using Student's unpaired t-test.
Pearson's Chi-square was used to analyse categorical data.
Missing group bias was analysed by testing the difference
between the respondents and non-respondents regarding
two-year HRQOL data, using unpaired t-tests.
The parametric methods as statistic analytic techniques
were chosen in order to adjust for the sampling weights
design in the reference group, regarding normative values
for SF-36. The reference group was randomly selected
from the population registry and weight-adjusted for age
to fit with the age distribution for the patient group in this
study. For the SF-36, items within each domain were
coded, scored and summarized to derive the eight
domains. The scores were then translated into a 0-100
scale where 0 indicated the worst possible HRQOL and
100 the best, according to the manual and interpretation
guide for SF-36 [47]. SF-36 scores were computed if the
respondent answered half or more of the items on the
scale; i.e., a person-specific mean score was calculated
based on the non-missing items [47]. The analysis
included only participants who had completed the seven-
year follow-up.
Statistical analyses regarding aim (i) employed Student's
paired t-test within each fracture group, to measure the
change between two-year and seven-year follow-up. To
determine the mean value differences between hip and
vertebral groups regarding change, we used Student's
unpaired t-test and ANCOVA while controlling for the
effect of covariates, age, new co-morbidity since two-year
follow-up and new low-energy fracture since two-year fol-
low-up. We also reassembled the entire group into the
groups new fracture since two-year follow-up (n = 29), no new
fracture since two-year follow-up (n = 38), new co-morbidity
since two-year follow-up (n = 46) and no co-morbidity since
two-year follow-up (n = 21).
Regarding aim (ii), the SF-36 of the fracture and reference
groups were compared using Student's unpaired t-test. To
determine the differences between hip and vertebral
groups we used ANCOVA while controlling for the effect
of covariates, age, new co-morbidity since two-year fol-
low-up and new low-energy fracture since two-year fol-
low-up.
With regard to aim (iii), a partial correlation was used in
which the relationship is measured, controlling for the
effect the covariates have on both variables. Variables in
the partial correlation were the eight SF-36 dimensions
and static balance on dominant leg with eyes open, hand-
grip strength on dominant hand, spinal deformity index
(SDI), physical activity, bone mineral density in hip total,
and fall frequency the past year. The covariates were age,
new co-morbidity since two-year follow-up, new low-
energy fracture since two-year follow-up (dichotomous
variables, yes = 1 or no = 2) and fracture group (vertebral
= 1 hip = 2). Differences were defined as significant if the
level of p-value was < 0.05 (2-sided) [48]. All statistical
analyses were performed using SPSS® for Windows version
15.0 (Statistical Package for the Social Sciences, SPSS Inc.,
Chicago, IL).
Results
Patient Characteristics
Of the 67 patients in the total study group, 42 had suf-
fered a vertebral fracture and 25 a hip fracture shortly
before the baseline study (inclusion fracture). The mean
age (SD) of the entire study group was 75.5 (4.6), range
64-82 years at seven-year follow-up. A total of 51% were
married or cohabiting.
At seven-year follow-up, 29/67 women had sustained one
or more new clinical low-energy fractures, in total 49 frac-
tures since two-year follow-up. More patients in the verte-
bral group (22/42), than in the hip fracture group (7/25),
had sustained a new clinical fracture. In the hip fracture
group at seven-year follow-up, nine women were identi-
fied as having one or more vertebral fractures. Six of these
women had no previous thoracolumbar radiographs, and
the true baseline prevalence and the seven-year incidence
of vertebral fracture in this group are unclear. In one
woman the vertebral fractures were known before the
inclusion, and two women had new vertebral fractures
compared with the previous radiographs.
Back pain during the past 14 days was reported to be dis-
turbing (GRS >30 mm) by 36/42 in the vertebral fracture
group and by 15/25 in the hip fracture group, a significant
difference (p = 0.02). In the vertebral fracture group, 48%
took painkillers (analgesics) regularly, 24% sometimes
and 28% never. In the hip fracture group, 32% took pain-
killers regularly, 20% sometimes and 48% never, a non-
significant difference (p  = 0.263). The most frequently
used painkillers were paracetamol (93%), opioids (44%)
and NSAID (41%) alone or in combination, regularly or
as required.BMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
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Bisphosphonate treatment was currently being used by
34% women, 15/42 and 8/25 respectively, p = 0.76. Most
patients took a supplement of calcium in combination
with vitamin D, 86% in the vertebral group and 70% in
the hip group. Seven were active smokers (10%). Overall,
69% women reported one or more new co-morbid condi-
tions of greater importance since two-year follow-up. The
incidence of new co-morbidity did not differ between the
fracture groups. The total number of reported new co-
morbid conditions was 71 (42 in the vertebral group and
29 in the hip group), the most frequent being cardiac dis-
ease, 25 (18 and 7, respectively), rheumatic or muscu-
loskeletal, 15 (9 and 6, respectively) and bronchi-
pulmonary disorders, 7 (3 and 4, respectively). Further
basic characteristics of the two fracture groups are pre-
sented in Table 1.
SF-36 Longitudinal Change - between two and seven-years
The vertebral fracture group had no statistically significant
changes in any SF-36 domains except bodily pain, which
had decreased significantly at seven-year follow-up, indi-
cating increased pain. The hip fracture group had no sig-
nificant changes in any domains (Table 2). However,
between the fracture groups there were no significant
mean value differences in the change between two and
seven years, or after controlling for covariates, age, new
co-morbidity and new fracture.
The group with new fracture (n = 29), of whom 22
belonged to the vertebral group, had significantly lower
values at seven-year follow up regarding role-physical,
bodily pain, general health and social function (all p <
0.01). The group with no new fracture (n = 38), of whom
20 belonged to the vertebral group, had no significant
changes. The group with new co-morbidity (n = 46) had
no significant changes, and neither the group without new
co-morbidity (n = 21).
SF-36 at Seven-year Follow-up
The vertebral fracture group had significantly lower scores
than the reference group in all domains, except for general
health and mental health.
Women with hip fracture did not differ from the reference
group regarding any SF-36 domain, but better values were
found for their mental health (Table 3).
The vertebral fracture group had significantly lower values
for bodily pain, vitality, role-emotional function and
mental health compared to the hip fracture group after
controlling for covariates, age, new co-morbidity and new
fracture (Table 4).
Regarding differences between vertebral and hip groups,
the covariate age was significantly related to physical func-
tioning, role-physical, bodily pain and vitality. The covari-
ate new co-morbidity was significantly related to role-
physical, bodily pain, vitality and role-emotional. The
covariate new fracture was significantly related to role-
physical, bodily pain and social functioning.
Table 1: Characteristics of participants, by fracture group, at seven-year follow-up
Vertebral group
n = 42
Hip group
n = 25
p-value
Age, yr, mean (SD) 75.8 (4.7) 75.0 (4.7) 0.50
Weight (kg) (SD) 69.5 (16.1)1 70.0 (10.8) 0.91
Height (cm) (SD) 158.4 (7.0)1 162.1 (5.5)1 0.03
Body mass index, mean (SD) 27.5 (5.0)1 26.6 (4.0)1 0.48
Static balance, one-leg second (SD) 8.9 (10.5)2 7.0 (8.3) 0.43
Handgrip, kilo, mean (SD) 16.7 (6.6)2 19.8 (5.0) 0.04
Back pain (GRS), mean (SD) 52 (22) 38 (27) 0.36
SDI (SD) 7.8 (6.1)2 2.3 (4.2)1 <0.01
BMD Lumb, Z-score SD 0.494 0.732 0.52
BMD Hip total, Z-score SD -0.183 -0.432 0.38
BMD Femoral neck, Z-score SD -0.053 -0.352 0.22
Participants with new co-morbidity since 2-year follow-up, % 67 72 0.65
Fall last year, % 38 32 0.62
Participants with new clinical fracture since 2-year follow-up, % 52 28 0.05
Total number new clinical fracture since 2-year follow-up (n) 36 13 -
Distal forearm (n) 3 2 -
Proximal humerus (n) 2 1 -
Hip (n) 6 1 -
Vertebrae (n) 16 2 -
Other (n) 9 7 -
Significance level p < 0.05 is given in bold.
Missing individuals 1 = 1, 2 = 2, 3 = 3, 4 = 7.BMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
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Table 2: HRQOL (SF-36) mean values in different fracture groups at two-year and seven-year follow-up
SF-36 Vertebral
Two-year
group
Seven-year
n p-value* Hip
Two-year
group
Seven-year
n p- value*
PF 52.2 (21.8)a 50.2 (26.2) 41 p = 0.567 57.1 (22.1) 58.2 (21.1) 25 p = 0.805
RP 38.5 (41.4) 26.9 (38.5) 40 p = 0.110 58.0 (44.3) 41.0 (39.4) 25 p = 0.124
BP 49.7 (23.8) 41.6 (23.7) 41 p = 0.022 64.5 (24.0) 60.6 (26.7) 25 p = 0.477
GH 56.1 (23.5) 56.1 (24.3) 40 p = 0.983 69.9 (20.5) 65.4 (17.6) 25 p = 0.230
VT 47.5 (23.6) 47.4 (25.1) 41 p = 0.991 66.2 (23.1) 63.2 (18.1) 25 p = 0.424
SF 73.8 (25.7) 66.2 (28.1) 41 p = 0.085 84.5 (18.8) 83.0 (18.4) 25 p = 0.718
RE 65.0 (43.3) 54.2 (45.1) 40 p = 0.230 76.0 (39.1) 80.0 (33.3) 25 p = 0.559
MH 71.6 (22.8) 70.9 (22.6) 40 p = 0.415 79.4 (16.4) 82.7 (12.7) 25 p = 0.287
PF: Physical Functioning, RP: Role-Physical, BP: Bodily Pain, GH: General Health,
VT: Vitality, SF: Social Functioning, RE: Role-Emotional, MH: Mental Health.
a Values in parentheses correspond to standard deviations.
*Significant tests: paired t-test
p-value: longitudinal change since two-year follow-up in different fracture groups
Significance level p < 0.05 is given in bold.
Table 3: HRQOL (SF-36) mean values in reference and different fracture groups at seven-year follow-up
SF-36 Reference group
n = 804
Vertebral group
n = 42
Hip group
n = 25
p-value*
PF 62.7 (26.7)a 50.4 (25.9) 58.2 (21.1) p1 = 0.004 p2 = 0.404
RP 55.9 (44.9) 27.4 (37.8) 41.0 (39.4) p1<0.001 p2 = 0.075
BP 59.0 (27.5) 41.6 (23.5) 60.6 (26.7) p1<0.001 p2 = 0.777
GH 58.2 (22.8) 55.8 (24.4) 65.4 (17.6) p1 = 0.515 p2 = 0.055
VT 58.0 (25.4) 48.0 (25.1) 63.2 (18.1) p1 = 0.013 p2 = 0.173
SF 77.3 (26.3) 67.0 (28.3) 83.0 (18.4) p1 = 0.013 p2 = 0.145
RE 71.3 (40.6) 54.0 (45.4) 80.0 (33.3) p1 = 0.020 p2 = 0.212
MH 74.7 (21.0) 71.2 (22.3) 82.7 (12.7) p1 = 0.296 p2 = 0.005
PF: Physical Functioning, RP: Role-Physical, BP: Bodily Pain, GH: General Health, VT: Vitality,
SF: Social Functioning, RE: Role-Emotional, MH: Mental Health.
a Values in parentheses correspond to standard deviations.
*Significant tests: unpaired t-test
p1 comparison between vertebral and reference groups
p2 comparison between hip and reference groups
Significance level p < 0.05 is given in bold.BMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
Page 8 of 13
(page number not for citation purposes)
Clinical Tests
Handgrip strength was significantly better in the hip frac-
ture group, 19.8 (SD 5.0), compared with that of patients
with vertebral fracture, 16.7 (SD 6.6). Static balance,
standing on one's dominant leg with one's eyes open, did
not differ between the fracture groups. Body height was
significantly higher in the hip fracture group. Height loss
did not differ significantly between the groups (p = 0.63),
with a mean loss since baseline visit of 21 mm (SD 19) in
the vertebral fracture group and 19 mm (SD 16) in the hip
fracture group. Further basic characteristics of the two frac-
ture groups are shown in Table 1.
Bone Mineral Density
Bone mineral density (BMD) did not differ significantly
between the vertebral and hip fracture groups. According
to the WHO criteria [44], among women with vertebral
fracture, 41% had osteoporosis (T-score ≤-2.5), 54% had
osteopenia/low BMD (T-score <-1 and >-2.5) and 5% nor-
mal value (T-score ≥-1.0) in the hip and/or spine. In the
hip fracture group, 50% had osteoporosis, 42% had oste-
openia/low BMD and 8% normal value. Additional BMD
Z-score data are presented in Table 1.
Vertebral Fracture Assessment
According to the lateral radiographs of the spine in the
present seven-year follow-up, 51 women had one or more
vertebral fractures (nine of whom originally had a hip
fracture as inclusion fracture). Sixteen women in the hip
fracture group had no vertebral fracture. In the group with
vertebral fracture(s), SDI was 7.8 (6.1 SD) and range 1-25,
and in the hip fracture group SDI was 2.3 (4.2 SD) and
range 0-15. Seventeen patients had one vertebral fracture
and eight patients had two fractures, and as many as 48%
of the women had three to nine vertebral fractures. Two
patients had nine vertebral fractures, SDI 23 and 25,
respectively.
Partial Correlations
In the total fracture group (n = 67), physical activity corre-
lated positively with all domains except the role-emo-
tional one, static balance showed a significantly positive
correlation to most of the SF-36 domains, except social
function and role-emotional function. Also, handgrip
strength showed a significantly positive correlation to
role-physical, vitality and mental health. Fall frequency
showed negative correlation with bodily pain and vitality.
BMD in the hip and SDI was not significantly correlated
with SF-36. These data show the relationship between the
two variables, controlling for the effect of covariates
(Table 5).
Discussion
The present study, which to our knowledge is the longest
published prospective follow-up study regarding HRQOL
after vertebral or hip low-energy fracture in routine health
care, supports and provides more details to the hypothesis
that vertebral fractures have a severe long-term impact on
HRQOL, assessed using the SF-36.
The vertebral group scored lower than did the reference
group in most domains at seven-year follow-up. Also,
bodily pain had deteriorated between two and seven years
and might be explained by new fracture. The total group
with new fracture since two-year follow up also had lower
values at seven-year follow-up, which can be interpreted
as the vertebral and hip fracture groups with subsequent
fractures (all fractures, not only new vertebral ones) hav-
ing poorer self-rated health, measured using the SF-36 at
seven-year follow-up. A recent study with five years of pro-
spective data about the long-term impact of incident frac-
tures on HRQOL supports these findings [30]
The hip fracture group had stable values in all domains
between two and seven years. Regarding the hip fracture
group, it should be noted that the mean age of the patients
was 68 yr at the time of the fracture, and most of them
were able to return to active life. Hip fracture at this rela-
tively early age is thus mainly a transient problem for the
patient in contrast to the case of vertebral fracture. The hip
fracture group, despite the incident or prevalent vertebral
fracture(s) (mainly subclinical fractures) in nine women,
Table 4: HRQOL (SF-36) adjusted mean values in vertebral and 
hip fracture groups at seven-year follow-up
SF-36 Vertebral group
n = 42
Hip group
n = 25
p-value*
PF 51.6 (44.5-58.8)a 56.0 (46.7-65.4) p = 0.464
RP 30.5 (20.0-41.1) 35.7 (21.8-49.5) p = 0.563
BP 42.9 (36.1-49.6) 58.5 (49.7-67.3) p = 0.007
GH 56.2 (49.3-63.1) 64.9 (55.9-73.9) p = 0.136
VT 48.5 (42.3-54.7) 62.3 (54.2-70.4) p = 0.010
SF 68.5 (61.1-75.9) 80.4 (70.7-90.0) p = 0.060
RE 54.7 (42.0-67.3) 78.9 (62.3-95.4) p < 0.026
MH 71.2 (65.4-77.1) 82.7 (75.0-90.4) p < 0.023
PF: Physical Functioning, RP: Role-Physical, BP: Bodily Pain, GH: 
General Health,
VT: Vitality, SF: Social Functioning, RE: Role-Emotional, MH: Mental 
Health.
a Values in parentheses correspond to 95% confidence intervals.
*Significant tests: ANCOVA, means controlling for the effect of 
covariates, age, new co-morbidity, and new fracture since two-year 
follow-up.
Significance level p < 0.05 is given in bold.BMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
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did not differ from the reference group regarding HRQOL
after seven years, and even had better values for mental
health.
In this study the vertebral fracture group had lower scores
than the hip fracture group in bodily pain, vitality, role-
emotional function and mental health at seven-year fol-
low-up after controlling for age, new fracture and new co-
morbidity.
These findings support the suggestions from previous
cross-sectional studies that pain and disability after verte-
bral fracture do not fade away [4,24,25] unless effective
treatment is given [20,21].
The patients were prescribed, and most took, treatment
(usually bisphosphonates, calcium and vitamin D) for the
first three years, but at seven-year follow-up only 34%
were still on active anti-osteoporosis treatment, and their
true compliance is not known. Is this due to a lack of con-
tinued prescription or to non-compliance by the patients?
The effect of more intensive treatment strategies should be
evaluated further, for both pharmacological and non-
pharmacological treatments. Increased bone mineral den-
sity and reduced fracture incidence are a good start, but
patients' well-being also has to be taken into account.
According to current recommendations, all patients still
fulfilled the criteria for active anti-osteoporosis treatment
[49].
The partial correlations show relationships between
HRQOL and physical activity, static balance, and hand-
grip strength, and in some domains fall frequency, despite
controlling for covariates such as age, fracture group, new
fracture and new co-morbidity. Static balance, expressed
as the ability to stand on one leg with one's eyes open, is
often used as a clinical test of balance, and is considered
to be sensitive to age-related changes in balance [41] and
an important predictor of injurious falls in older people
[50]. Bohannon et al. [41] found that participants aged
70-79 years (n = 31, men and women) could maintain
this position for a mean of 14 s. Healthy Swedish women
aged 70 years held this position for a mean of 18 s [40].
The women in this study maintained their balance while
standing on their dominant leg with their eyes open for an
average of 8 s; this low value suggests an impairment of
static balance. Handgrip strength was significantly lower
in the vertebral fracture group than in the women with hip
fracture. The mean values in the hip fracture group did not
differ from the reference values in American women of the
same mean age [39]. A recent population study from Swe-
den assessed handgrip strength in 75 and 80-year-old
women. Handgrip strength was measured using the
JAMAR, with the test being repeated three times and the
highest value being recorded. In women at risk for malnu-
trition, handgrip strength was 19.7 kg and in women at no
risk 23.5. Compared to this study, the vertebral group had
lower handgrip strength (16.7) with both groups for risk
and no risk for malnutrition. The handgrip strength in the
hip fracture group (19.8) is at the level of women at risk
for malnutrition [51]. Patients with hip fracture are found
to be thinner with lower lean body mass than age-
matched controls [52].
Dixon et al. (2005) found an association between low
handgrip strength and low bone mineral density and an
increased risk of incident vertebral fracture in the Euro-
pean Prospective Osteoporosis study (EPOS) [53].
The results support the value of the SDI [45] as a measure
to be used in clinical routine. This approach is more
objective and reproducible than a visual qualitative
assessment of vertebral fracture [46]. Accurate radio-
Table 5: Partial correlation of: SF-36 domains vs. static balance, handgrip strength, SDI, BMD hip total, fall frequency and physical 
activity, at seven-year follow-up
Static balance
n = 60
Handgrip strength
n = 60
SDI
n = 60
BMD hip tot
n = 60
Fall frequency
n = 60
Physical activity
n = 60
SF-36:
PF 0.48*** 0.17 -0.02 0.02 -0.16 0.72***
RP 0.50*** 0.28* -0.05 0.22 -0.09 0.45***
BP 0.27* 0.22 -0.05 -0.10 -0.29* 0.37**
GH 0.36** 0.25 -0.03 0.00 -0.24 0.35**
VT 0.42** 0.39** -0.11 0.06 -0.35** 0.37**
SF 0.19 0.14 -0.10 -0.01 -0.19 0.30*
RE 0.21 0.17 -0.21 0.13 -0.26 0.16
MH 0.29* 0.29* -0.00 0.13 -0.22 0.31*
PF: Physical Functioning, RP: Role-Physical, BP: Bodily Pain, GH: General Health,
VT: Vitality, SF: Social Functioning, RE: Role-Emotional, MH: Mental Health.
Partial correlations, controlling for the effect of age, fracture group, new co-morbidity and new fracture since two-year follow-up.
Significance level p < 0.05 is given in bold. *p < 0.05 **p < 0.01 ***p < 0.001BMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
Page 10 of 13
(page number not for citation purposes)
graphic diagnosis is important, as the underdiagnosis of
vertebral fractures may lead to decreased rates of diagnosis
and treatment of osteoporosis in women [8].
In the present group, as many as 29 of 67 (43%) had one
or more new fractures during the five-year period (since
two-year follow-up). This high fracture incidence may be
ascribed to the degree of osteoporosis as well as to the less
ambitious treatment.
A prospective three-year study showed that for each new
vertebral deformity, HRQOL deteriorated further [28].
Similar results have been reported by others [7,10,26].
The question of whether the poor HRQOL and the poor
survival in patients with vertebral fracture are actually due
to the fractures, increased biological age or concomitant
diseases is important and may be pivotal to attitudes
regarding osteoporosis treatment [9,11,12]. Recent results
from a three-year controlled study with an annual intrave-
nous injection of zoledronate showed not only reduced
fracture incidence but also an increased survival [54].
These studies support the hypothesis that osteoporosis
and fracture may be causative factors of chronic back pain
and excess mortality. Mortality is reported to increase after
vertebral as well as hip fracture [9-12]. The reduced phys-
ical function, higher incidence of new fractures and higher
mortality in our vertebral fracture group likewise suggest
that vertebral fracture predicts a poorer prognosis than a
hip fracture does in this age group. The causes of excess
mortality after vertebral fractures are still obscure,
although cancer and pulmonary death have been sug-
gested [11]. The findings of reduced handgrip strength
and static balance in the vertebral fracture group may sup-
port a relationship with general frailty. But which is the
chicken and which is the egg?
Approximate expected mortality during the five-year
period (since the two-year follow-up) for the two fracture
groups was assessed on age-specific death risks in Sweden
2006 [55]. The age-adjusted number of expected deaths in
the group with vertebral fracture (n = 53) and hip fracture
(n = 38) was five (CI 2-9) and four (CI 1-7), respectively.
Five-year mortality in the vertebral fracture group (10/53)
was high, but the study was not designed to identify
causes of excessive death rates.
The results of this study thus support previous reports that
vertebral fractures are associated with increased pain,
impaired physical function [4,7], decreased HRQOL
[26,28,30] and higher morbidity and mortality [9,10,12].
Pharmacological as well as non-pharmacological treat-
ments and methods have to be considered. Malmros et al.
(1998) found positive effects from a ten-week ambulatory
exercise programme with physiotherapy on chronic pain,
balance, physical function and quality of life [56]. There is
a lack of studies and evidence of non-pharmacological
treatments effects assessed with self-reported quality of
life questionnaires after osteoporosis fracture. The devel-
opment of strategies to improve HRQOL after vertebral
fracture remains an important goal for future research.
Some methodological issues need to be considered. Mul-
tiple testing increases the risk of obtaining a significant
difference purely by chance; therefore, the results should
be interpreted with caution. However, if a simple sequen-
tially rejective multiple test procedure (Holm's method)
had been used [57], most of the results in the study would
still be significant, because most had a p < 0.01.
For the most part, our results show clinically significant
differences. A half standard deviation is a conservative
estimate of clinical significance, but the minimally impor-
tant difference may be below 1/2 SD in specific cases [58].
Many patients adapt over time, and their perceptions of
HRQOL may change. Learning to cope with problems is a
well-recognized characteristic of the chronically ill. Also,
patients may meet others whose condition is worse or bet-
ter than their own, which can lead to a revaluation of their
own internal standards and values.
Response shift is a psychological phenomenon that
results from coping caused by the affecting internal stand-
ards or values [59]. A response shift cannot be excluded in
this study; the HRQOL response patterns could have been
affected by choice of comparator group. A study con-
ducted by Fayers et al. found that the majority of ques-
tionnaire participants reported using different frames of
reference for comparison when completing an annual
HRQOL questionnaire [60]. Only one-third of the partic-
ipants reported using the same comparison reference
frame at each yearly interval.
In this study, we chose to use a generic HRQOL question-
naire instrument, to be able to make comparisons with a
reference group. It is possible that the outcome would
have been different if we had used an osteoporosis-spe-
cific questionnaire on HRQOL. However, at the start of
the baseline study there was no disease-specific question-
naire available that had been translated into Swedish and
validated.
A limitation of the study is the small number of women,
particularly in the hip fracture group. A baseline radio-
graph of the lumbar and thoracic spine was performed for
only one woman with a hip fracture as inclusion fracture
and, therefore, the true prevalence of vertebral fractures in
this group at baseline is unclear.BMC Musculoskeletal Disorders 2009, 10:135 http://www.biomedcentral.com/1471-2474/10/135
Page 11 of 13
(page number not for citation purposes)
The reference group was handled like a normal back-
ground population, and we lacked data concerning co-
morbidity and fracture status, which would have been
advantageous to have in order to adjust for possible cov-
ariates. The missing group of 26% since two-year follow-
up could have affected the result. A dropout analysis
between the missing group and the women participating
in the seven-year follow-up, using data from the two-year
follow-up, showed that the missing group had signifi-
cantly lower values regarding the SF-36 as well as lower
weight, body mass index and bone mineral density in the
hip. This can be interpreted as the missing group having
poorer health, and the result at seven-year follow-up pos-
sibly leading to an overestimation of SF-36 scores for the
vertebral and hip group.
The low doctor compliance with treatment may be
regarded as a limitation, but indeed allows the study
expose the symptom development in a poor-treatment or
non-treatment situation. We studied only Caucasian
women, and the results may not apply to other ethnic
groups or men.
Strengths of the study are its prospective design and the
fact that all participants were investigated using well
defined methods. The advantages of using the SF-36 were
the possibility to assess and compare HRQOL in individ-
uals suffering from different co-morbidity and supplying
reference data for the general population. Another
strength is the large reference group for the SF-36 recruited
from the same general population during 2006.
Conclusion
This study demonstrates that women who had had verte-
bral fracture as inclusion fracture had remaining pro-
nounced reduction of HRQOL at seven-year follow-up. A
decreased HRQOL since the two-year follow-up might be
explained by new fracture.
In the age span of 64-82 years (mean age 75.5), the prev-
alence of vertebral fracture suggests more negative impact
on HRQOL, more severe osteoporosis and a poorer prog-
nosis than a hip fracture does. The differences in HRQOL
between vertebral and hip fracture at seven-year follow-up
cannot be explained by age, new disease or new fracture.
Women with hip fracture did not differ from the reference
group regarding HRQOL, despite vertebral fractures in
nine women.
The long-term reduction of HRQOL and its relationship
to physical activity, static balance, and handgrip strength
raise questions that warrant more investigation. Further-
more, HRQOL studies with more effective treatment
including non-pharmacological intervention are needed,
and the development of strategies to prevent loss of func-
tion and improve HRQOL after vertebral fracture remains
an important goal for future research.
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